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Molecular mechanisms of renal hypertrophy: Role of p27Kip1. ing genetic program of individual cells [1]. Cells commit-
There are two fundamentally different growth responses for ted to proliferation progress through the cell cycle, dou-
cells comprising the nephron: hyperplasia or hypertrophy. Cells ble their DNA content, and finally divide during mitosis.that progress through the normal cell cycle double their DNA
In contrast, hypertrophic cells are often arrested in thecontent and eventually divide during mitosis. Those cells that
G1-phase of the cell cycle. They increase their size, pro-hypertrophy stop the growth process in the G1-phase of the
cell cycle; while they increase in size, protein and RNA content, tein, and RNA content, but do not duplicate their set of
they cannot duplicate their set of chromosomes because they chromosomes because they never pass the S-phase of
never pass through the S-phase of the cell cycle. Hypertrophy the cell cycle. Although observations in other organsmay be an early compensatory mechanism to initially replace
than the kidney suggest that hypertrophy of cells maythe loss of functioning tissue, however, this maladaptive process
also occur in the G2-phase subsequent to DNA replica-eventually fosters progressive loss of renal function. Since pro-
gression of the cell through the G1 to S-phases is regulated by tion and result in enlarged cells with polyploidy, there
cyclins D, E and A, which in turn bind and activate cyclin is little evidence that such a mechanism is operative in
dependent kinases (CDKs), evidence has been accumulating renal cells [1]. The regeneration of functional tubularon a particular CDK-inhibitor protein, p27Kip1, which is specu-
epithelium after acute tubular necrosis is often viewedlated to be a key to the complex process of the G1/S cell
as a classic example of a proliferative growth responsecycle transition. This article examines the mechanisms of the
proliferative growth response following acute tubular necrosis, restoring renal function. Although such a regeneration
and compensatory hypertrophy of glomerular and tubule cells, of the tubule certainly requires initial proliferation of
with a particular focus on the protein p27Kip1.
surviving epithelial cells, the situation is much more com-
plex because cells need to migrate along an intact base-
ment membrane, to replicate, and finally, to differentiateThe various types of cells composing the nephron
into polarized tubular epithelium. In contrast, compensa-have, under normal conditions, a low turnover [1]. In a
tory renal enlargement following more chronic loss ofclassic study in the field, Pabst and Sterzel investigated
functioning tissue in the adult kidney results in hypertro-the turnover of glomerular cells in the normal rat by
phy of tubular cells. Compensatory hypertrophy of glo-autoradiography [2]. A constant renewal rate of glomer-
merular as well as tubular cells may, although initiallyular cells of 1% per day was mainly attributed to endo-
restoring functional renal tissue, ultimately result in mal-thelial cells, whereas mesangial cells exhibited a very low
adaptation and loss of renal function [1, 3]. The morpho-proliferation rate. However, a variety of pathophysiolog-
logical consequence is the development of tubulointersti-ical stimuli results in growth processes of glomerular and/
tial fibrosis and glomerulosclerosis [1, 3].or tubular cells [1, 3]. Quiescent renal cells can undergo
either hyperplasia or hypertrophy, two fundamentally
different growth responses. It is reasonable to assume MOLECULAR MECHANISMS OF ANGIOTENSIN
that the synthesis, release, and action of cytokines and II-MEDIATED HYPERTROPHY OF PROXIMAL
growth factors are important in influencing growth pro- TUBULAR CELLS
cesses of renal cells [1]. Different cell types along the Because the contribution of individual cells to overall
nephron may exhibit a different growth response to the hypertrophy of the kidney is difficult to assess only in
same factor, depending on the intrinsic activation state vivo, we developed a cell culture system in which angio-
of the cells, receptor expression for potential growth tensin II (Ang II), as a single factor, induces hypertrophy
factors, influence of growth suppressers, and the underly- of murine proximal tubular cells (MCT cells) as well as
of porcine LLC-PK1 cells [4, 5]. Ang II stimulates cellular
hypertrophy of cultured proximal tubular cells as deter-Key words: turnover of glomerular cells, cell proliferation, growth re-
sponse, endothelial cells, hypertrophic cells. mined by stimulated protein synthesis, an increase in
total RNA content, and the enlargement of cell size 1999 by the International Society of Nephrology
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without an accompanying DNA synthesis [4, 5]. Cell that Ang II-stimulated hypertrophy and induction of
p27Kip1 are partly mediated by TGF-b [12]. Immunopre-cycle analysis revealed that Ang II-treated cells are ar-
rested in the G1-phase and do not progress into the S-phase cipitation experiments revealed that p27Kip1 preferen-
tially associated with CDK4 in Ang II-treated LLC-PK1[4, 6]. This hypertrophic action of Ang II is mediated
through high-affinity Ang II type-1 receptors (AT1-recep- cells and that the activity of this kinase was inhibited
after Ang II treatment, suggesting that p27Kip1 binds totors), involves the activation of pertussis-toxin–sensitive
Gi proteins, and depends on a decrease in intracellular CDK4-cyclin D1 complexes [12]. Treatment of LLC-PK1
cells with p27Kip1 antisense, but not missense oligonucleo-cAMP [6]. Ang II also stimulates the transcription and
biosynthesis of transforming growth factor-b (TGF-b) tides, abolished the Ang II-mediated cell hypertrophy, as
measured by de novo protein synthesis and total proteinin proximal tubular cells [7]. The Ang II-mediated hyper-
trophy partly depends on this induction and the autocrine content and facilitated entry into the S-phase of the cell
cycle [12]. These findings strongly suggest that the induc-action of TGF-b, because a neutralizing anti–TGF-b an-
tibody abolished the Ang II-induced hypertrophy of tion of p27Kip1 is pivotal for the hypertrophy of tubular
cells stimulated by Ang II. In a more recent study, weMCT cells [7]. In agreement with these observations are
findings by Franch et al demonstrating that application of investigated which signal transduction pathways may be
involved in Ang II-stimulated expression of p27Kip1 inexogenous TGF-b prevented S-phase entry of proximal
tubular cells incubated with epidermal growth factor proximal tubular cells. Because Ang II may stimulate
the intracellular generation of reactive oxygen species(EGF) [8]. The Ang II-mediated stimulation of TGF-b
expression may also be one explanation for the observa- such as superoxide anions (O2•) in vascular smooth mus-
cle cells [13], we investigated whether O2• production istion that the hypertrophic response to Ang II is greater
in medium with high-glucose concentration because high involved in Ang II-mediated hypertrophy in proximal
tubular cells. A single dose of 1027 m Ang II for fourglucose by itself also stimulates TGF-b expression [9].
Ang II as well as mitogens such as EGF induce early hours readily stimulated the accumulation of O2• in LLC-
PK1 and MCT cells as measured by the lucigenin method.immediate genes in cultured proximal tubular cells [4, 10].
Because these genes are exclusively expressed in the The addition of two different antioxidants [Tiron and
N-acetylcysteine (NAC)] completely abolished measur-G1-phase, these findings suggest that proliferative as well
as hypertrophic stimuli both induce a G0- to G1-phase able O2• concentrations, suggesting specificity of the assay.
This effect was transduced by AT1 receptors and wastransit of quiescent cells, but only the proliferative stimu-
lus enables cells to progress further through the S-phase inhibited in the presence of 5 to 10 mm diphenylene
iodinium (DIP), a flavoprotein inhibitor. Furthermore,and complete the cell cycle [5, 6, 10].
Progression from G1 to the S phase is regulated by transient transfection of cells with p22phox [a subunit
of the membrane NAD(P)H oxidase complex] antisense,the accumulation of cyclins D, E, and A [11]. These
cyclins bind and activate different cyclin-dependent ki- but not sense, oligonucleotides abolished the Ang II-
induced generation of O2•, indicating an involvementnases (CDKs). The cyclin D-CDK4 and cyclin E-CDK2
complexes are catalytically active during the late G1 of membrane NAD(P)H oxidase. In addition, Ang II
incubation (2 to 4 hr) also induced p22phox expression.phase and are implicated in the regulation of G1/S transit
[11]. Evidence accumulating during the last few years Ang II-stimulated de novo protein synthesis was attenu-
ated by DIP and NAC, as well as in cells transfectedrevealed that CDK-cyclin complexes are regulated in
their activities through association with inhibitory pro- with p22phox antisense oligonucleotides. The Ang II-
induced expression of p27Kip1 protein was reduced byteins called CDK inhibitors [11]. These CDK inhibitors
can be grouped in two families, whereas p15, p16, and similar treatments. However, the generation of oxygen
species by xanthine supplementation also stimulatedp18 specifically inhibit CDK4 and CDK6, interact and
inhibit the proteins p21, p27Kip1, and p28 with a broad p27Kip1 expression and induced hypertrophy in LLC-PK1
cells.range of CDK-cyclin complexes [11]. Because p27Kip1 is
important in the regulation of CDK-cyclin complexes, Therefore, Ang II-mediated activation of membrane-
bound NAD(P)H oxidase, probably by an increase inwhich are active at the G1/S-phase transition, we investi-
gated whether p27Kip1 expression in tubular cells is modi- p22phox transcripts, is principally responsible for this
induction. Inhibition of this enzyme complex by variousfied during Ang II-induced hypertrophy [12]. Compared
with cells grown in serum-free medium, Ang II treatment means or direct neutralization of O2• with antioxidants
attenuated Ang II-stimulated hypertrophy and p27Kip1enhanced p27Kip1 protein expression but did not influence
mRNA expression of this CDK inhibitor [12]. This p27Kip1 expression, indicating that reactive oxygen species play
a pivotal role in Ang II-induced tubular hypertrophy byinduction was mediated through AT1 receptors and
was attenuated, to some extent, in the presence of a stimulation of p27Kip1 expression. These data suggest a
novel mechanism of how Ang II, through the inductionneutralizing anti–TGF-b antibody. Furthermore, exoge-
nous TGF-b also stimulated p27Kip1 expression, indicating of O2•, can modulate cell cycle regulation. In addition,
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Fig. 1. Pivotal role of p27Kip1 in the induction
of hypertrophy in various renal cells. For ex-
ample, high-glucose medium stimulates ex-
pression of p27Kip1 in cultured mesangial cells
through the activation of protein kinase C.
On the other hand, angiotensin II (Ang II)-
mediated hypertrophy also depends on stimu-
lated expression of p27Kip1, which is probably
mediated by reactive oxygen species. High-
glucose medium as well as Ang II also induce
transforming growth factor-b, which, in turn,
may also increase p27Kip1 expression. p27Kip1
interacts with cyclin-dependent kinase (CDK)-
cyclin complexes and inhibits their activity.
The consequence is a G1-phase arrest of cells
with hypertrophy and probably an accumula-
tion of extracellular matrix proteins.
the fact that O2• per se, even independent of Ang II [17]. The quantitation of p27Kip1-positive glomerular cells
showed a significant increase of these cells in db/db micechallenge, may stimulate p27Kip1 expression has an impact
in understanding the regulation of tubular growth in compared with nondiabetic db/1 animals. To test for
the influence of hyperglycemia on cell cycle arrest anda wide variety of pathophysiological situations such as
reperfusion after ischemia or tubulointerstitial inflam- p27Kip1 expression, mesangial cells were isolated from
db/1 and db/db mice. There was a similar basal prolifera-mation.
tion when these cells were grown in normal glucose-
containing medium (100 mg/dl). However, raising the
ROLE OF p27KIP1 IN MESANGIAL
glucose concentration to 275 to 450 mg/dl induced cell
HYPERTROPHY INDUCED BY
cycle arrest in db/1 as well as db/db mesangial cells [17].
HIGH GLUCOSE
Furthermore, p27Kip1 expression was comparable in both
Angiotensin II-mediated hypertrophy of proximal tu- cell lines in normal glucose, but increased in high glucose
bular cells is not the only situation in which p27Kip1 plays medium [17]. These studies demonstrated that p27Kip1
a prominent role. We have previously shown that murine expression is enhanced in diabetic animals. This induc-
mesangial cells (MMCs) cultured in a high-glucose me- tion appears to be due to hyperglycemia. The expression
dium are arrested in the G1-phase of the cell cycle and of p27Kip1 may be important in cell cycle arrest and hyper-
undergo hypertrophy [14]. This observation is of patho- trophy of mesangial cells during early diabetic nephrop-
physiological relevance because glomerular hypertrophy athy.
occurs early in diabetes and may be an important factor
in the progression of diabetic nephropathy [15]. Incuba-
CONCLUSIONtion of MMCs, in the absence of other factors, for 48 to
96 hours in medium containing high d-glucose (450 Accumulating evidence suggests that renal hypertro-
phy as an early compensatory mechanism to replace themg/dl) stimulated p27Kip1 protein expression [16]. These
effects were independent of the osmolarity of the me- loss of functioning tissue may ultimately turn into a mal-
adaptive process fostering progressive loss of renaldium [16]. High-glucose–stimulated expression of p27Kip1
involved activation of protein kinase C (PKC) and was function. The molecular mechanisms underlying such
a hypertrophic growth response are, however, largelypartly dependent on induction of TGF-b [16]. Further-
more, glomerular p27Kip1 protein, but not mRNA expres- unknown. We have established and extensively investi-
gated two in vitro models of renal hypertrophy (Ang IIsion, was strongly enhanced in diabetic db/db mice, a
model of diabetes mellitus type II, compared with non- stimulation of proximal tubular cells and high glucose
incubation of mesangial cells) in which cells are arresteddiabetic db/1 littermates [17]. Immunohistochemistry
studies revealed that this stimulated expression was in the G1-phase of the cell cycle. The induction and
accumulation of p27Kip1 play a pivotal role in these modelsmainly restricted to nuclei of mesangial cells, but glomer-
ular endothelial cells occasionally also stained positive (Fig. 1). This CDK inhibitor binds to various CDK-cyclin
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induced hypertrophy of cultured murine proximal tubular cells iscomplexes, inhibits their activities, and prevents progres-
mediated by endogenous transforming growth factor-b. J Clin In-
sion of the cell cycle. Cells arrested in the G1-phase vest 92:1366–1372, 1993
8. Franch HA, Shay JW, Alpern RJ, Preisig PA: Involvement ofproduce more protein, extracellular matrix components,
pRB family in TGFb-dependent epithelial cell hypertrophy. J Celland enlarge. These findings may be important in the
Biol 129:245–254, 1995
deciphering of molecular processes causing renal hyper- 9. Wolf G, Neilson EG, Goldfarb S, Ziyadeh FN: The influence
of glucose concentration on angiotensin II-induced hypertrophytrophy and may eventually offer therapeutic manipula-
of proximal tubular cells in culture. Biochem Biophys Res Communtions of the cell cycle to modify adaptive renal growth
176:902–909, 1991
processes. 10. Wolf G, Kuncio GS, Sun MJ, Neilson EG: Expression of homeo-
box genes in a proximal tubular cell line derived from adult mice.
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